Search

Olga V. Tcherkasskaya

Examiner (ID: 2038, Phone: (571)270-3672 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
932
Issued Applications
464
Pending Applications
127
Abandoned Applications
382

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20320021 [patent_doc_number] => 20250332109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL [patent_app_type] => utility [patent_app_number] => 19/221438 [patent_app_country] => US [patent_app_date] => 2025-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19221438 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/221438
COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL May 27, 2025 Pending
Array ( [id] => 20066938 [patent_doc_number] => 20250205160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG [patent_app_type] => utility [patent_app_number] => 19/076661 [patent_app_country] => US [patent_app_date] => 2025-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19076661 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/076661
STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG Mar 10, 2025 Pending
Array ( [id] => 20066938 [patent_doc_number] => 20250205160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG [patent_app_type] => utility [patent_app_number] => 19/076661 [patent_app_country] => US [patent_app_date] => 2025-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19076661 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/076661
STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG Mar 10, 2025 Pending
19/107055 GADUSOL-CONTAINING SUNSCREEN FORMULATIONS Feb 26, 2025 Pending
Array ( [id] => 20293791 [patent_doc_number] => 20250319034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => MICROSPHERE PRODUCTION METHOD [patent_app_type] => utility [patent_app_number] => 19/059219 [patent_app_country] => US [patent_app_date] => 2025-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19059219 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/059219
MICROSPHERE PRODUCTION METHOD Feb 19, 2025 Pending
Array ( [id] => 20293791 [patent_doc_number] => 20250319034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => MICROSPHERE PRODUCTION METHOD [patent_app_type] => utility [patent_app_number] => 19/059219 [patent_app_country] => US [patent_app_date] => 2025-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19059219 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/059219
MICROSPHERE PRODUCTION METHOD Feb 19, 2025 Pending
Array ( [id] => 19845183 [patent_doc_number] => 20250090534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 18/948795 [patent_app_country] => US [patent_app_date] => 2024-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18948795 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/948795
Phosphodiesterase-5 Inhibitor Combinations, Methods of Making, and Methods of Use Thereof Nov 14, 2024 Pending
Array ( [id] => 20254793 [patent_doc_number] => 12427126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Niclosamide formulations and methods of use [patent_app_type] => utility [patent_app_number] => 18/926688 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 10362 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926688 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/926688
Niclosamide formulations and methods of use Oct 24, 2024 Issued
Array ( [id] => 20254793 [patent_doc_number] => 12427126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Niclosamide formulations and methods of use [patent_app_type] => utility [patent_app_number] => 18/926688 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 10362 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926688 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/926688
Niclosamide formulations and methods of use Oct 24, 2024 Issued
Array ( [id] => 20254793 [patent_doc_number] => 12427126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-30 [patent_title] => Niclosamide formulations and methods of use [patent_app_type] => utility [patent_app_number] => 18/926688 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 4 [patent_no_of_words] => 10362 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18926688 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/926688
Niclosamide formulations and methods of use Oct 24, 2024 Issued
Array ( [id] => 19860588 [patent_doc_number] => 20250099374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => Pharmaceutical Formulation [patent_app_type] => utility [patent_app_number] => 18/654460 [patent_app_country] => US [patent_app_date] => 2024-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654460 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/654460
Pharmaceutical Formulation May 2, 2024 Pending
Array ( [id] => 20401203 [patent_doc_number] => 12491162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Formulations of tegavivint [patent_app_type] => utility [patent_app_number] => 18/642595 [patent_app_country] => US [patent_app_date] => 2024-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 35 [patent_no_of_words] => 8102 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18642595 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/642595
Formulations of tegavivint Apr 21, 2024 Issued
Array ( [id] => 19447196 [patent_doc_number] => 20240307326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => DOSAGE FORMS OF MIRDAMETINIB [patent_app_type] => utility [patent_app_number] => 18/608748 [patent_app_country] => US [patent_app_date] => 2024-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608748 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/608748
DOSAGE FORMS OF MIRDAMETINIB Mar 17, 2024 Pending
Array ( [id] => 19447196 [patent_doc_number] => 20240307326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => DOSAGE FORMS OF MIRDAMETINIB [patent_app_type] => utility [patent_app_number] => 18/608748 [patent_app_country] => US [patent_app_date] => 2024-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608748 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/608748
DOSAGE FORMS OF MIRDAMETINIB Mar 17, 2024 Pending
Array ( [id] => 20218473 [patent_doc_number] => 20250281404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER [patent_app_type] => utility [patent_app_number] => 18/599091 [patent_app_country] => US [patent_app_date] => 2024-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18599091 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/599091
COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER Mar 6, 2024 Pending
Array ( [id] => 20218473 [patent_doc_number] => 20250281404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER [patent_app_type] => utility [patent_app_number] => 18/599091 [patent_app_country] => US [patent_app_date] => 2024-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18599091 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/599091
COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER Mar 6, 2024 Pending
Array ( [id] => 19331255 [patent_doc_number] => 20240245685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/436072 [patent_app_country] => US [patent_app_date] => 2024-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18436072 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/436072
PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF Feb 7, 2024 Abandoned
Array ( [id] => 19186292 [patent_doc_number] => 20240165205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => INSULIN FORMULATIONS AND METHODS OF USING SAME IN PRETERM INFANTS [patent_app_type] => utility [patent_app_number] => 18/424936 [patent_app_country] => US [patent_app_date] => 2024-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424936 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/424936
INSULIN FORMULATIONS AND METHODS OF USING SAME IN PRETERM INFANTS Jan 28, 2024 Pending
Array ( [id] => 19682355 [patent_doc_number] => 20250000900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => HIGH MOLECULAR IODINE CONCENTRATION COMPOSITIONS, PHARMACEUTICAL FORMULATIONS, PREPARATION AND USES [patent_app_type] => utility [patent_app_number] => 18/423060 [patent_app_country] => US [patent_app_date] => 2024-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18423060 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/423060
HIGH MOLECULAR IODINE CONCENTRATION COMPOSITIONS, PHARMACEUTICAL FORMULATIONS, PREPARATION AND USES Jan 24, 2024 Pending
Array ( [id] => 19186111 [patent_doc_number] => 20240165024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => MYCOPHENOLATE ORAL SUSPENSION [patent_app_type] => utility [patent_app_number] => 18/422105 [patent_app_country] => US [patent_app_date] => 2024-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18422105 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/422105
MYCOPHENOLATE ORAL SUSPENSION Jan 24, 2024 Abandoned
Menu